// App-Quantinova.ai

[THU0408] : HOW WE ARE TREATING OUR SYSTEMIC PATIENTS WITH PRIMARY SJOGREN SYNDROME? ANALYSIS OF 1120 PATIENTS (GEAS-SS SPANISH REGISTRY)

Researchers

Presenter

  • H. Gheitasi

Principal Investigators

  • R. Solans

  • B. Pinilla

  • X. Bosch

  • J. Nava-Mateos

  • B. Diaz-Lopez

  • L. Morera-Morales

  • S. Retamozo

  • M. Ramos-Casals

  • P. Brito Zeron

  • G. Fraile

  • C. Suarez-Cuervo

  • A. Casanovas

  • F.J. Rascon

  • R. Qanneta

  • R. Perez-Alvarez

  • M. Ripoll

  • M. Akasbi

Medical Centers

  • Department of Internal Medicine, Hospital Gregorio Maranon, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Sjogren's syndrome

  • Thrombocytopenia

  • Chronic pain

  • Neutropenia

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • Rituximab

  • IVIG

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved